These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cryoprecipitate in the management of haemophilia in Kenya. Taylor JR; Ahluwalia NS; Morrison CJ; Kaviti JN; Cardwell CL East Afr Med J; 1969 Feb; 46(2):121-8. PubMed ID: 5798053 [No Abstract] [Full Text] [Related]
5. [The application of epsilon-aminocaproic acid in the treatment of hemophilia]. Gugler E; Käser H; Bütler R Schweiz Med Wochenschr; 1966 Mar; 96(12):386-93. PubMed ID: 5984001 [No Abstract] [Full Text] [Related]
6. [Treatment of hemophilia]. Bellucci S Rev Infirm; 1985 Mar; 35(5):34-7. PubMed ID: 3845667 [No Abstract] [Full Text] [Related]
7. [Therapeutic effect on hemophilia by AMCHA]. Gebauer D; Heigel K Med Klin; 1969 Feb; 64(9):378-82. PubMed ID: 5305740 [No Abstract] [Full Text] [Related]
9. [Pharmacotherapy of hemophilia with the preparation of Lagochilus inebrians BGE]. Akopow IE Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(1):72-83. PubMed ID: 4104085 [No Abstract] [Full Text] [Related]
10. Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography. Young G; Blain R; Nakagawa P; Nugent DJ Haemophilia; 2006 Nov; 12(6):598-604. PubMed ID: 17083509 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic treatment of patients with haemophilia A or haemophilia B. Vox Sang; 2005 Jan; 88(1):62-7. PubMed ID: 15663726 [No Abstract] [Full Text] [Related]
12. Immune tolerance and the immune modulation protocol. Berntorp E; Nilsson IM Vox Sang; 1996; 70 Suppl 1():36-41. PubMed ID: 8869467 [No Abstract] [Full Text] [Related]
13. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion. Santagostino E; Gringeri A; Cultraro D; Tradati F; Siracusano L; Marinoni A; Mannucci PM Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):371-80. PubMed ID: 7580830 [TBL] [Abstract][Full Text] [Related]
14. The German Registry of immune tolerance treatment in hemophilia--1999 update. Lenk H; Haematologica; 2000 Oct; 85(10 Suppl):45-7. PubMed ID: 11187870 [TBL] [Abstract][Full Text] [Related]
15. [Long-term follow-up of consumption of plasma, blood and antihemophilic globulin in patients with hemophilia]. Pudlák P; Horák J Vnitr Lek; 1968 Jan; 15(1):1-8. PubMed ID: 5720983 [No Abstract] [Full Text] [Related]
16. Home treatment for hemophilia. Hasiba U; Gorenc TJ; Oskins PB; Spero JA; Lewis JH Pa Med; 1974 Dec; 77(12):50-1. PubMed ID: 4462071 [No Abstract] [Full Text] [Related]
17. Prophylaxis in children with hemophilia: is it the optimal treatment? Lusher JM Thromb Haemost; 1997 Jul; 78(1):726-9. PubMed ID: 9198246 [No Abstract] [Full Text] [Related]
18. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography. Sultan Y; Boyeldieu D; Stieltjes N Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717 [TBL] [Abstract][Full Text] [Related]
19. [On treatment trials of hemophiliacs with epsilon-aminocaproic acid (Epsamon)]. Fonio A Schweiz Med Wochenschr; 1966 Dec; 96(51):1723-6. PubMed ID: 5973382 [No Abstract] [Full Text] [Related]
20. Immune tolerance induction and the treatment of hemophilia. Malmö protocol update. Berntorp E; Astermark J; Carlborg E Haematologica; 2000 Oct; 85(10 Suppl):48-50; discussion 50-1. PubMed ID: 11187871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]